Tg Therapeutics (TGTX) Retained Earnings (2010 - 2026)
Tg Therapeutics' (TGTX) quarterly Retained Earnings came in at $1.8 billion in Q1 2026, up 223.03% year-on-year from $571.3 million in Q1 2025, and up 0.84% quarter-over-quarter from $1.8 billion in Q4 2025.
Tg Therapeutics (TGTX) Retained Earnings (2010 - 2026) Analysis & Trends
Tg Therapeutics' Retained Earnings history runs 17 years deep, the most recent figure standing at $1.8 billion for Q1 2026.
- On a quarterly basis, Retained Earnings rose 223.03% year-over-year to $1.8 billion in Q1 2026; TTM through Mar 2026 was $1.8 billion, a 223.03% increase from a year earlier, with the FY2025 full-year figure at $1.8 billion, up 219.68% from the prior year.
- Retained Earnings rose to $1.8 billion in Q1 2026 per TGTX's latest filing, from $1.8 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $1.8 billion in Q1 2026 and bottomed at -$1.6 billion in Q2 2023.
- The 5-year median for Retained Earnings is -$1.5 billion (2022), against an average of -$733.7 million.
- Across the five-year window, Retained Earnings plunged 195.29% in 2022 and surged 223.03% in 2026, its largest moves.
- Year by year, Retained Earnings stood at -$1.5 billion in 2022, then jumped by 214.21% to $1.7 billion in 2023, then plunged by 189.26% to -$1.5 billion in 2024, then jumped by 219.68% to $1.8 billion in 2025, then gained by 0.84% to $1.8 billion in 2026.
- Per Business Quant, the three latest TGTX Retained Earnings figures stand at $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn | 1.85 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.85 Bn |
| Dec 31, 2025 | 1.83 Bn |
| Sep 30, 2025 | 1.81 Bn |
| Jun 30, 2025 | -1.50 Bn |
| Mar 31, 2025 | -1.50 Bn |
| Dec 31, 2024 | -1.53 Bn |
| Sep 30, 2024 | -1.60 Bn |
| Jun 30, 2024 | -1.56 Bn |
| Mar 31, 2024 | -1.50 Bn |
| Dec 31, 2023 | 1.71 Bn |
| Sep 30, 2023 | -1.50 Bn |
| Jun 30, 2023 | -1.61 Bn |
| Mar 31, 2023 | -1.60 Bn |
| Dec 31, 2022 | -1.50 Bn |
| Sep 30, 2022 | -1.47 Bn |
| Jun 30, 2022 | -1.40 Bn |
| Mar 31, 2022 | -1.40 Bn |
| Dec 31, 2021 | -1.33 Bn |
| Sep 30, 2021 | 1.55 Bn |
| Jun 30, 2021 | -1.15 Bn |